The aged gut in inflammatory bowel diseases

Minerva Gastroenterologica e Dietologica

Volumn 61, Issue 4, 2015, Pages 235-247

  Ardesia, M ^a   Villanacci, V ^b   Fries, W ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b SPEDALI CIVILI   (Italy)

Author keywords

Aged; Biologic therapy; Colitis, ulcerative; Crohn disease; Diagnosis, differential; Immunologic factors

Indexed keywords

ANTIBIOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

AGING; CLINICAL FEATURE; COLITIS; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DIVERTICULOSIS; DYSBIOSIS; GASTROINTESTINAL TRACT; HISTOLOGY; HOSPITALIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MASTICATION; MORBIDITY; MORTALITY; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; REVIEW; SENESCENCE; SWALLOWING; AGED; INFLAMMATORY BOWEL DISEASES; INTESTINE; MICROBIOLOGY; MICROFLORA; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYPHARMACY;

AGED; AGING; COMORBIDITY; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MICROBIOTA; POLYPHARMACY;

EID: 84962529694     PISSN: 1121421X     EISSN: 18271642     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Britton E, McLaughlin JT. Ageing and the gut. Proc Nutr Soc 2013;72:173-7.
2. Rayner CK, Horowitz M. Physiology of the ageing gut. Curr Opin Clin Nutr Metab Care 2013;16:33-8.
3. D'Souza AL. Ageing and the gut. Postgrad Med J 2007;83:44-53.
4. Tran L, Greenwood-Van Meerveld B. Age-associated remodeling of the intestinal epithelial barrier. J Gerontol A Biol Sci Med Sci 2013;68:1045-56.
5. Saweirs WM, Andrews DJ, Low-Beer TS. The double sugar test of intestinal permeability in the elderly. Age Ageing 1985;14:312-5.
6. Beaumont DM, Cobden I, Sheldon WL, Laker MF, James OF. Passive and active carbohydrate absorption by the ageing gut. Age Ageing 1987;16:294-300.
7. Saltzman JR, Kowdley KV, Perrone G, Russell RM. Changes in small-intestine permeability with aging. J Am Geriatr Soc 1995;43:160-4.
8. Kevans D, Turpin W, Madsen K, Meddings J, Shestopaloff K, Xu W, et al. Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease. Inflamm Bowel Dis 2015;21:879-87.
9. Valentini L, Ramminger S, Haas V, Postrach E, Werich M, Fischer A, et al. Small intestinal permeability in older adults. Physiol Rep 2014;2:e00281.
10. Saffrey MJ. Cellular changes in the enteric nervous system during ageing. Dev Biol 2013;382:344-55.
11. Korsak K, Dolatshad NF, Silva AT, Saffrey MJ. Ageing of enteric neurons: oxidative stress, neurotrophic factors and antioxidant enzymes. Chem Cent J 2012;6:80.
12. Bitar K, Greenwood-Van Meerveld B, Saad R, Wiley JW. Aging and gastrointestinal neuromuscular function: Insights from within and outside the Gut. Neurogastroenterol Motil 2011;23:490-501.
13. Dongarra ML, Rizzello V, Muccio L, Fries W, Cascio A, Bonaccorsi I, et al. Mucosal immunology and probiotics. Curr Allergy Asthma Rep 2013;13:19-26.
14. Man AL, Gicheva N, Nicoletti C. The impact of ageing on the intestinal epithelial barrier and immune system. Cell Immunol 2014;289:112-8.
15. Schmucker DL, Thoreux K, Owen RL. Aging impairs intestinal immunity. Mech Ageing Dev 2001;122:1397-411.
16. Moore WE. Holdeman LV Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974;27:961-79.
17. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
18. Peterson CT, Sharma V, Elmén L, Peterson SN. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clin Exp Immunol 2015;179:363-77.
19. Brussow H. Microbiota and healthy ageing: observational and nutritional intervention studies. Microb Biotechnol 2013;6:326-34.
20. Tiihonen K, Ouwehand AC, Rautonen N. Human intestinal microbiota and healthy ageing. Ageing Res Rev 2010;9:107-16.
21. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2011;108(Suppl 1):4586-91.
22. Claesson MJ, Jeffery IB, Conde S, Power SE, O'Connor EM, Cusack S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012;488:178-84.
23. Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 2010;5:e10667.
24. Thibault R, Blachier F, Darcy-Vrillon B, de Coppet P, Bourreille A, Segain JP Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency. Inflamm Bowel Dis 2010;16:684-95.
25. Zhang YJ, Li S, Gan RY, Zhou T, Xu DP, Li HB. Impacts of gut bacteria on human health and diseases. Int J Mol Sci 2015 Apr. 2;16:7493-519.
26. Fries W, Comunale S. Ulcerative colitis: pathogenesis. Curr Drug Targets 2011;12:1373-82.
27. Cao Y, Shen J, Ran ZH. Association between Faecalibacterium prausnitzii reduction and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Gastroenterol Res Pract 2014;2014:872725.
28. Friswell M, Campbell B, Rhodes J. The role of bacteria in the pathogenesis of inflammatory bowel disease. Gut Liver 2010;4:295-306.
29. Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014;63:1275-83.
30. Varela E, Manichanh C, Gallart M, Torrejón A, Borruel N, Casellas F, et al. Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis. Aliment Pharmacol Ther 2013;38:151-61.
31. Biagi E, Candela M, Turroni S, Garagnani P, Franceschi C, Brigidi P. Ageing and gut microbes: perspectives for health maintenance and longevity. Pharmacol Res 2013;69:11-20.
32. Bojic D, Markovic S. Terminal ileitis is not always Crohn's disease. Ann Gastroenterol 2011;24:271-5.
33. Dilauro S, Crum-Cianflone NF. Ileitis: when it is not Crohn's Disease. Curr Gastroenterol Rep 2010;12:249-58.
34. Jump RL. Clostridium difficile infection in older adults. Aging health 2013;9:403-14.
35. Dignass A, Eliakim R, Magro F, Maaser C, Chowers Y, Geboes K, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 2012;6:965-90.
36. Lavallèe C, Laufer B, Pépin J, Mitchell A, Dubé S, Labbé AC. Fatal Clostridium difficile enteritis caused by the BI/NAP1/027 strain: a case series of ileal C. Difficile infections. Clin Microbiol Infect 2009;15:1093-9.
37. Münch A, Langner C. Microscopic colitis: clinical and pathologic perspectives. Clin Gastroenterol Hepatol 2015;13:228-36.
38. Ohlsson B. New insights and challenges in microscopic colitis. Therap Adv Gastroenterol 2015;8:37-47.
39. Magro F, Langner C, Driessen A, Ensari A, Geboes K, Mantzaris GJ, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis 2013;7:827-51.
40. Bohr J., Wickbom A, Hegedus A, Nyhlin N, Hultgren Hôrnquist E, Tysk C. Diagnosis and management of microscopic colitis: current perspectives. Clin Exp Gastroenterol 2014;7:273-84.
41. Mann NS, Hoda KK. Segmental colitis associated with diverticulosis: systematic evaluation of 486 cases with meta-analysis. Hepatogastroenterology 2012;59:2119-21.
42. Ierardi E, Hassan C, Zullo A, De Francesco V, Valle ND, Prencipe S, et al. Segmental colitis associated with diverticula: a rare clinical entity and a new challenge for the gastroenterologist. Dig Liver Dis 2009;41:794-7.
43. Freeman HJ. Relevance of segmental colitis with diverticulosis (SCAD) to other forms of inflammatory bowel disease. Can J Gastroenterol 2009;23:439-40.
44. Tursi A, Elisei W, Picchio M, Forti G, Giorgetti G, Faggiani R, et al. Letter: diverticulosis in inflammatory bowel diseases. Aliment Pharmacol Ther 2014;39:899-900.
45. Tursi A, Elisei W, Giorgetti GM, Aiello F, Brandimarte G. Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease. Aliment Pharmacol Ther 2011;33:358-65.
46. Tortora A, Purchiaroni F, Scarpellini E, Ojetti V, Gabrielli M, Vitale G, et al. Colitides. Eur Rev Med Pharmacol Sci 2012;16:1795-805.
47. Mohanapriya T, Singh KB, Arulappan T, Shobhana R. Ischemic colitis. Indian J Surg 2012;74:396-400.
48. Washington C, Carmichael JC. Management of ischemic colitis. Clin Colon Rectal Surg 2012;25:228-35.
49. Brandt LJ, Feuerstadt P, Longstreth GF, Boley SJ, American College of Gastroenterology. ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI). Am J Gastroenterol 2015;110:18-44.
50. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
51. Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Aliment Pharmacol Ther 2014;39:459-77.
52. Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF. IBD across the age spectrum: is it the same disease? Nat Rev Gastroenterol Hepatol 2014;11:88-98.
53. Charpentier C, Salleron J, Savoye G, Fumery M, Merle V, Laberenne JE, et al. Natural history of elderly-onset inflammatory bowel disease: a populationbased cohort study. Gut 2014;63:423-32.
54. Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, et al. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. J Crohns Colitis 2011;5:5-13.
55. Juneja M, Baidoo L, Schwartz MB, Barrie A 3rd, Regueiro M, Dunn M, et al. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci 2012;57:2408-15.
56. Jeuring S, Van den Heuvel T, Zeegers M, Hameeteman W, Romberg-Camps M, Oostenbrug L, et al. Is elderly-onset ulcerative colitis a different entity? Natural disease course and treatment response compared to adult-onset disease in the population-based lBD-SL cohort. J Crohns Colitis 2014;8(Suppl 1):S3-4.
57. Langholz E, Munkholm P, Krasilnikoff PA, Binder V Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997;32:139-47.
58. Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, et al. Epidemiology of inflammatory bowel diseases: new insights from a French populaton-based registry (EPIMAD). Dig Liver Dis 2013;45:89-94.
59. Zimmerman J, Gavish D, Rachmilewitz D. Early and late onset ulcerative colitis: distinct clinical features. J Clin Gastroenterol 1985;7:492-8.
60. Moum B, Ekbom A, Vatn MH, Aadland E, Sauar J, Lygren I, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective populationbased study in southeastern Norway, 1990-95. Scand J Gastroenterol 1997;32:1005-12.
61. Targownik LE, Singh H, Nugent Z, Bernstein CN. The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol 2012;107:1228-35.
62. Satsangi J. Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53.
63. Quezada SM, Steinberger EK, Cross RK. Association of age at diagnosis and Crohn's disease phenotype. Age Ageing 2013;42:102-6.
64. Viola A, Cantoro L, Monterubbianesi R, Castiglione F, Principi M, Frankovic I, et al. Crohn's Disease (CD) in the elderly - an IG-IBD study. J Crohns Colitis 2014;8(Suppl 1):S293-4.
65. Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL; ECCO-EpiCom. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis 2014;8:1351-61.
66. Størdal K, Jahnsen J, Bentsen BS, Moum B. Pediatric inflammatory bowel disease in southeastern Norway: a five-year follow-up study. Digestion 2004;70:226-30.
67. Turunen P, Kolho KL, Auvinen A, Iltanen S, Huhtala H, Ashorn M. Incidence of inflammatory bowel disease in Finnish children, 1987-2003. Inflamm Bowel Dis 2006;12:677-83.
68. Jakobsen C, Bartek J Jr, Wewer V, Vind I, Munkholm P, Groen R, et al. Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease-a population-based study. Aliment Pharmacol Ther 2011;34:1217-24.
69. Gupta S, Saverymuttu SH, Keshavarzian A, Hodgson HJ. Is the pattern of inflammatory bowel disease different in the elderly? Age Ageing 1985;14:366-70.
70. Katz S, Feldstein R. Inflammatory bowel disease of the elderly: a wake-up call. Gastroenterol Hepatol (NY) 2008;4:337-47. [PubMed: 21990970]
71. Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis 2009;15:182-9.
72. Ventham NT, Kennedy NA, Duffy A, Clark DN, Crowe AM, Knight AD, et al. Nationwide linkage analysis in Scotland-Has mortality following hospital admission for Crohn's disease changed in the early 21st century? J Crohns Colitis 2014. pii: S1873-9946 (14) 00267-0.
73. Ikeuchi H, Uchino M, Matsuoka H, Bando T, Hirata A, Takesue Y, et al. Prognosis following emergency surgery for ulcerative colitis in elderly patients. Surg Today 2014;44:39-43.
74. Bautista MC, Otterson MF, Zadvornova Y, Naik AS, Stein DJ, Venu N, et al. Surgical outcomes in the elderly with inflammatory bowel disease are similar to those in the younger population. Dig Dis Sci 2013;58:2955-62.
75. Jess T, Frisch M, Simonsen J. Trends in overall and cause-specific mortality among patients with inflammatory bowel disease from 1982 to 2010. Clin Gastroenterol Hepatol 2013;11:43-8. [
76. Hadithi M, Cazemier M, Meijer GA, Bloemena E, Felt-Bersma RJ, Mulder CJ, et al. Retrospective analysis of old-age colitis in the Dutch inflammatory bowel disease population. World J Gastroenterol 2008 May 28;14(20):3183-7. [PubMed: 18506923]
77. Ha CY, Newberry RD, Stone CD, Ciorba MA. Patients with late-adult-onset ulcerative colitis have better outcomes than those with early onset disease. Clin Gastroenterol Hepatol 2010;8:682-7.
78. Marteau P, Probert CS, Lindgren S, Gassul M, Tan TG, Dignass A, et al. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study. Gut 2005;54:960-5.
79. Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol 2011;106(11):1889-97.
80. Ford AC, Kane SV, Khan KJ, Achkar JP, Talley NJ, Marshall JK, et al. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis. Am J Gastroenterol 2011;106:617-29.
81. Schoepfer AM, Bortolotti M, Pittet V, Mottet C, Gonvers JJ, Reich O, et al. The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease. Aliment Pharmacol Ther 2014;40:930-7.
82. Thomas TP. The complications of systemic corticosteroid therapy in the elderly. A retrospective study. Gerontology 1984;30:60-5.
83. Madanick RD. Proton pump inhibitor side effects and drug interactions: much ado about nothing? Cleve Clin J Med 2011;78:39-49.
84. Kotlyar DS, Lewis JD, Beaugerie L, Tierney A, Brensinger CM, Gisbert JP, et al. Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis. Clin Gastroenterol Hepatol 2015;13:847-58.
85. Peyrin-Biroulet L, Khosrotehrani K, Carrat F, Bouvier AM, Chevaux JB, Simon T, et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 2011;141:1621-8.
86. Brassard P, Bitton A, Suissa A, Sinyavskaya L, Patenaude V, Suissa S. Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases. Am J Gastroenterol 2014;109:1795-802.
87. Fries W, Viola A, Monterubbianesi R, Manetti N, Frankovic I, Pugliese D, et al. Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study. Gastroenterology 2015;148(Suppl 1):S-133.
88. Cottone M, Kohn A, Daperno M, Armuzzi A, Guidi L, D'Inca R, et al. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol 2011;9:30-5.
89. Lobaton T, Ferrante M, Rutgeerts P, Ballet V, Van Assche G, Vermeire S. Efficacy and safety of anti-TNF therapy in elderly patients with inflammatory bowel disease. Aliment Pharmacol Ther 2015;42:441-51.
90. Naganuma M, Kunisaki R, Yoshimura N, Takeuchi Y, Watanabe M. A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease. J Gastroenterol 2013;48:595-600.
91. Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008;134:929-36.
92. Masclee GM, Sturkenboom MC, Kuipers EJ. A benefit-risk assessment of the use of proton pump inhibitors in the elderly. Drugs Aging 2014;31:263-82.
93. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, et al. Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases. Aliment Pharmacol Ther 2015;41:1141-8.
94. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008;57:205-10.
95. Regnault H, Bourrier A, Lalande V, Nion-Larmurier I, Sokol H, Seksik P, et al. Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment. Dig Liver Dis 2014;46:1086-92.
96. Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, et al. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. World J Gastroenterol 2015;21:6728-35.
97. Ardesia M, Ferlazzo G, Fries W. Vitamin d and inflammatory bowel disease. Biomed Res Int 2015;2015:470805.
98. Nguyen GC, Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008;103:2272-80.
99. Cheddani H, Dauchet L, Charpentier C, Fumery M, Salleron J, Bouvier A-M, et al. Cancer in elderly-onset inflammatory bowel disease: a population-based study. Gastroenterology 2014;146(Suppl 1):S-101.
100. Biancone L, Michetti P, Travis S, Escher JC, Moser G, Forbes A, etal. European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis 2008;2:63-92.